TrialLancet (London, England)2019

Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.

Brian D Foy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.